Watch This Space: Reliance Advances Protein-Based COVID-19 Vaccine

Huge Group's Digital Prowess An Advantage?

Reliance Life Sciences, part of India’s largest private sector enterprise with a growing engagement in healthcare, is progressing an early-stage COVID-19 vaccine. A top executive underscores the potential to manufacture at scale and provide the protein-based candidate at a competitive price.

Aerial overhead view of trailer trucks delivering a vaccine. 3D rendering
Reliance Group's COVID-19 Vaccine Holds Promise • Source: Shutterstock

More from R&D

More from Scrip